Lorazepam Effects on Neuroimaging Measures

NCT04671836 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No longer interested in conducing study

Conditions

Lorazepam
Neuroimaging

Interventions

DRUG: Lorazepam 1Mg Tablet
DRUG: Placebo

Sponsor

Northwell Health